In response to increased research being performed in developing countries, many research ethics committees (RECs) have been established, but the quality of their ethics review systems remains unknown. Evaluating the performance of an REC remains a challenging task. Absent an accreditation process, a self-assessment mechanism would provide RECs a way to review their policies and processes against recognized international standards. We describe a self-assessment tool that was developed and reviewed by REC members and researchers from the Middle East. This tool reflects pragmatic aspects of human subjects protection, is based on international standards, is straightforward in its completion, and its items are relevant to the administrative processes that exist in many RECs in the developing world.
Accordingly, there has been a growing interest in establishing mechanisms to regulate and assess the operations and functions of RECs. Such efforts have included IRB registration coupled with audits or accreditation processes that assess IRB compliance with established regulations. For example, in the United States, the Office of Human Research Protections (OHRP) is the regulatory body responsible for compliance with the U.S. regulations for Protection of Human Subjects (Office for Human Research Protections, 2005) . Institutions engaged in federally funded human subjects research are required to provide written Assurances of Compliance to OHRP that describe the means the institution will employ to comply with the U.S. regulations and IRBs are required to register with OHRP. Similarly, the U.S. Food and Drug Administration (FDA) has jurisdiction over human clinical studies involving pharmaceuticals and medical devices (Food & Drug Administration, 2010) . Both OHRP and FDA enforce their regulations by conducting inspections of investigational sites and records of IRBs, sponsors, and principal investigators. In addition to these regulatory bodies, an accreditation effort has been instituted by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). This private organization evaluates an institution's Human Research Protection Program, including its IRB(s); accreditation is voluntary (Association for the Accreditation of Human Research Protection Programs, 2001) . In the United Kingdom, the National Research Ethics Service has developed an accreditation scheme that includes IRB registration, self-assessment, and regular audits of the IRBs (National Research Ethics Service, 2007) .
There are several examples of accreditation efforts in the developing world. The Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) established a two-step process for accreditation (Strategic Initiative for Developing Capacity in Ethical Review [SIDCER], 2002) . The first step involves an REC self-assessment process followed by an external survey mechanism. The survey includes interviews, assessment of documents and procedures, observation of the facilities, and observation of a full-board REC committee meeting. In South Africa and Nigeria, national regulations require RECs to register with their respective National Health Research Ethics Committees (National Health Research Ethics Committee, 2008; National Health Research Ethics Council, 2003) . There are also plans to conduct regular audits of the registered RECs that are based on these countries' guidelines for medical research. Finally, Jordan's Law of Clinical Studies requires IRBs to register with the Jordan Food and Drug Administration to ensure that they are meeting requirements related to members' diversity and qualifications; regular audits are not performed (Al-Khateeb, 2008; Jordan Food & Drug Administration, 2001 ).
Since only a few countries have a legal or regulatory framework for clinical research, an accreditation process consisting of an external review mechanism based on national standards is problematic for many countries in the developing world. Alternatively, one can conduct performance assessments of RECs to ensure the protection of human subjects and efficiency of REC functioning. Evaluating the performance of an REC, however, remains a challenging task. While there are no gold standards for determining effectiveness, suggested measures for assessing performance have focused on objective process indicators, such as turnaround times for research submissions and communications between RECs and investigators; as well as study-specific outcomes, including the number of protocols reviewed, the type of research reviewed, and the frequency of reported adverse events (Burke, 2005; Wolf, Croughan, & Lo, 2002) . Other attempts to measure performance have been based on subjective assessments by stakeholders in the research process, such as investigators and members of the RECs (Feldman & Rebholz, 2009; Gray, Cooke, & Tannenbaum, 1978; Rothstein & Phuong, 2007) . There have also been attempts to evaluate RECs by the use of external observers (Fauriel et al., 2004; Fitzgerald, Phillips, & Yule, 2006) . Finally, a self-assessment method might help RECs evaluate their performances and demonstrate to their stakeholders the legitimacy of their review mechanisms.
Several such self-assessment instruments are available. For example, the Office for Human Research Protections offers a self-assessment tool as part of its Quality Assurance/Quality Improvement Program (Office for Human Research Protections, 2005). However, this tool is mainly based on the U.S. regulations for human subjects protection and, hence, might not be applicable to RECs in developing countries. Similar concerns regarding applicability also apply to the self-assessment tool used by the UK's National Research Ethics Service. WHO/ TDR has published two guidelines, "Operational Guidelines for Ethics Committees That Review Biomedical Research" and "Surveying and Evaluating Ethical Review Practices" (WHO/TDR, 2000 , 2002 . However, the former publication is overly detailed in some subject areas (e.g., "communicating a decision" and "follow-up") and it leaves out important items relevant to REC functioning (e.g., resources and elements of informed consent and continuing review). The latter publication mainly serves as an aid for conducting a process for surveying RECs, including the types of documents to be reviewed. The previously mentioned SIDCER also offers a self-assessment tool, but their tool is long and includes many elements that might not be relevant to human subjects protection. Indeed, several commentators have voiced concerns that the oversight of RECs has been characterized by increasing requirements for meticulous documentation of compliance with regulations that are unrelated to harms of research participants (Fost & Levine, 2007) . It is therefore of little surprise that many requirements imposed by various self-assessment tools and accreditation process have little relationship to the protection of human research participants.
To achieve a more accessible self-assessment tool for RECs, we describe herein the process we undertook to develop such a tool. Our major goal was to develop a self-assessment tool that would reflect pragmatic aspects of human subjects protection, be based on international standards, be straightforward in its completion, and be relevant to the administrative process that exist in many RECs during their early stage of development.
Methods
The design of the self-assessment tool went through two different phases.
Initial Development
The The initial aim of the Working Group was to use elements that would measure the effectiveness of REC performance in terms of protecting the rights and welfare of research participants. However, there are no gold standards for determining effectiveness nor are there standards that can actually measure how well human participants are being protected by the use of standards. Instead, the working group considered standards that incorporate surrogate metrics considered foundational for effectiveness and protection. Such standards consisted of elements that refer to the following:
• Policies (e.g., dealing with conflict of interest and establishment of the REC)
• Structural elements (e.g., membership composition)
• Processes (e.g., submission of protocols, communicating a decision)
• Performance measures (e.g., consideration of certain ethical criteria in the review of protocols)
• Human, financial, and material resources.
Final Development
After development of the draft tool, the Working Group sent the tool to bioethics experts and Chairs of RECs in the Middle East (Sudan and Egypt) and asked them the following questions: (a) "Which items are not clear?" (b) "Which items are not important?" and (c) "What other items should be included?" We then presented the self-assessment tool to participants attending the 3rd Egyptian Network of Research Ethics Committees held in December 2009 for their general feedback. After incorporating relevant comments into the final draft of the tool, two of the authors (HJS and HS) weighted and assigned a point value to each element of the standards, which was subsequently reviewed by the other co-authors.
Results
Many of our reviewers submitted helpful comments to revise the initial draft of the tool. These included clarification of several terms (e.g., non-affiliated member, non-scientist); questioning of several items (e.g., importance of having the signature of the department chair on the submission form); and addition of several items (e.g., whether RECs have dedicated resources and whether the REC used a specific checklist in their review of research).
The final self-assessment tool is shown in Appendix A. The tool is divided into the following categories: (a) Organizational Aspects, (b) Membership and Educational Training, (c) Submission Arrangements and Materials, (d) Minutes, (e) Review Procedures, (f) Communicating a Decision, (g) Continuing Review, and (h) REC Resources. The tool shows the points assigned to each of the elements. We assigned 1, 2, or 5 points to each element. A maximum point score of 5 was assigned to those elements that we believed represent significant aspects of effective functioning for RECs. The maximum achievable point total is 200 points.
Discussion
The assurance of protections for research participants requires the establishment of standards for ethical review as well as the evaluation of the performance of RECs against such standards. In response to the increased conduct of clinical trials in the developing world, many RECs have been organized in many institutions. However, the extent to which they function is largely unknown. Ideally, the presence of a formal, external review mechanism can help evaluate and provide feedback to RECs. An accreditation process has been established by several organizations to evaluate RECs (Association for the Accreditation of Human Research Protection Programs, 2001; Strategic Initiative for Developing Capacity in Ethical Review [SIDCER], 2002), but the establishment of formal methods of accrediting RECs requires the acceptance and authority of an external body. Alternatively, a national regulatory body can institute an accreditation process. However, in many countries in the developing world, such regulatory bodies have yet to undertake such an active role in accrediting RECs. In the absence of an external body to perform evaluation and accreditation, an important intermediary step would constitute a self-review mechanism. Accordingly, we have developed a self-assessment tool by which RECs can evaluate their practices and appraise their performance against standards that were drawn primarily from international standards.
To be sure, other self-assessment instruments have been developed. For example, the OHRP has a QA self-assessment tool, but this tool is mainly based on the U.S. regulations and, hence, might not be applicable to countries that refer to international regulations. Also, this tool is lengthy (19 pages) and includes many elements that might not be relevant to human subjects protection. Other self-assessment tools include those developed by SIDCER, the United Kingdom's NHS, and AAHRP. These tools also suffer from being lengthy and also contain many elements not relevant to human subjects protection.
A major goal of our project was to develop a tool that would be relevant to the early stages of REC development that exist in most of the institutions in the developing countries. Accordingly, such a tool should include standards that are important in the achievement of the protection of research participants, yet avoid including those standards that represent narrow interpretations of guidelines that are not relevant to studies being conducted in their institutions. Also, the inclusion of too many detailed elements would make the use of such a tool overly burdensome to complete. Commentators have voiced concerns that the oversight of RECs has been characterized by increasing requirements for meticulous documentation of compliance with regulations that are unrelated to harms to research participants (Fost & Levine, 2007) .
A major limitation of the use of a self-assessment tool is the objectivity and accuracy with which an REC would have in completing such a tool. Such a limitation, however, is inherent in any attempt at quality improvement. It is difficult to know whether an REC's use of our developed tool to evaluate and revise their practices achieves a level of human subject protection that would compare with the use of any of the previously mentioned longer selfassessment tools. Without a gold standard for effectiveness, such a comparison would be difficult to achieve. However, we believe that the elements contained in our developed tool capture the essential aspects of a functioning REC. As such, we do not believe that obtaining a high score on our tool would provide a false sense of reassurance of an REC's functioning. Although our self-assessment tool (as similar to the other self-assessment tools) does not measure directly the effects of an REC on human subjects protections, we have included standards that evaluate surrogate indices of functioning, which include the presence of policies, structural elements, review processes, and resources.
Our major goal was to ensure that RECs would actually use some kind of self-assessment tool that would help them evaluate and enhance their operations. As such, our tool is only nine pages long and, hence, would not be overly burdensome to complete. Also, our use of a scoring system would allow other RECs to gauge how they compare with the aggregate scores obtained from other RECs in their region. Such a scoring system is lacking in the previously mentioned self-assessment tools. Finally, our tool may also serve as a useful guide to assist National Regulatory Bodies or Ministries of Health in developing their own accrediting standards.
Best Practices
The self-assessment tool developed for RECs represents a quality improvement process, whereby such committees can obtain a measure of the appropriateness of their policies and processes in reviewing research that is based on recognized international standards. Such a process would enable RECs to ensure that they achieve best practices regarding their policies on conflicts of interest, membership requirements, education requirements for their members, review requirements, meeting requirements, and communications with other stakeholders involved in the research endeavor. Such a quality improvement process would enhance the public trust in the performance of research.
Research Agenda
While we had several Chairs of RECs review this tool and offer feedback, the next logical step would be to have several RECs use the tool, and thereby obtain more generalizable data on the usefulness of such a tool in assessing and enhancing REC operational performance. Also, feedback from a range of different RECs would be instrumental in understanding better the relevance of the items on the self-assessment tool, thereby resulting in a product that gains more universal acceptance. Furthermore, since the individual items of the selfassessment tool have been scored, it would be possible to obtain aggregate data from different RECs. Such data would serve as a benchmark from which individual RECs can compare their results. Accordingly, we have plans to conduct an anonymous web-based study collecting the self-assessments of different RECs in the Middle East. Such a study would provide additional support for the instrument's validity and utility. We welcome collaborators from the other regions of the world.
Educational Implications
The use of a self-assessment tool provides several educational opportunities. First, its individual use can provide RECs a better understanding of the necessary changes they need to incorporate in their policies, processes, and educational requirements of their members. Second, the collection of aggregate data would provide national policymakers and international organizations an opportunity to better understand the state of affairs regarding the maturity and functionality of RECs in the developing world. Such information can help with the allocation of necessary resources as well as the development of educational opportunities that can optimize the functionality of these RECs. include investigating issues involving women & reproductive health. She received funding to develop a distance-learning course in this area. She also has interests in research ethics; she has developed curriculum in research ethics and interacts with the Research Ethics Committee at Cairo University. She helped conceptualize the focus of this paper, contributed to the development of the self-assessment tool, and reviewed the manuscript.
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SUBMISSION ARRANGEMENTS AND MATERIALS (Maximum 12 POINTS)

Submission Arrangements of Research Protocols 1 point each
Item Yes No
Does the REC publish guidelines for submission of applications for the review by the REC?
Does the REC require investigators to use a specific application form for the submission of their protocols to the REC?
Does the REC have an informed consent template to help guide investigators in the writing of their informed consent forms?
Does the REC require approval and signature of the department chair (or another individual) of the research protocol prior to the submission?
Does the REC require a deadline for investigators to submit protocols for full committee review?
Submission Materials
Which of the following items are requested from the Principal Investigators when they submit their research protocol to the REC? 1 point each Do the minutes reflect that members were asked whether they had a conflict of interest regarding any of the protocols to be discussed and indicate that such members did not participate in the decision making process of the relevant protocols?
Do the minutes document that a quorum was present for all actions requiring a decision?
Do the minutes document that all actions included at least one scientist in the review and participated in the decision making process?
Do the minutes document that all actions included at least one non-scientist in the review who participated in the decision making process?
Do the minutes document that all actions included at least one person who is not affiliated with the institution in the review and participated in the decision making process?
Do the minutes record the name of REC members who abstained from the decision making process and provided the reason for abstention?
Do the minutes record the name of REC members who were excused from the discussion and decision making process due to a conflict of interest?
Do the minutes reflect, when applicable, a discussion of the controversial aspects of the research protocol? Are members asked at the beginning interest regarding any the meeting as to whether they had a conflict of the protocols to be discussed and indicate that such members did not participate in the decision on the relevant protocols?
POLICIES REFERRING TO REVIEW PROCEDURES (Maximum 11 POINTS)
Does the REC have a policy for communicating a decision?
Does the REC have a policy for follow-up review?
REVIEW OF SPECIFIC PROTOCOL ITEMS (Maximum 43 POINTS)
Scientific Design and Conduct of the Study 1 point each
Item Yes No
Does the REC review the suitability of the investigators' qualifications to conduct the study?
Does the REC review the adequacy of the clinical site, including the supporting staff, available facilities, and emergency procedures?
Does the REC take into account prior scientific reviews or do they review the appropriateness of the study design in relation to the objectives of the study, the statistical methodology, and the potential for addressing the objectives with the smallest number of research participants?
Considerations of Risks and Benefits 1 point each
Item Yes No
Does the REC identify the different risks of the research protocol?
Does the REC determine whether risks have been minimized?
Does the REC determine whether the risks are greater than minimal risk based on a written definition of minimal risk?
Does the REC evaluate the probable benefits of the research to the participants?
Does the REC evaluate the importance of the knowledge to society that may reasonably be expected to result from the research?
Does the REC evaluate whether the risks to research participants are reasonable in relation to any anticipated benefits to participants and the importance of the knowledge to be gained by society?
Selection of Research Participants 1 point each
Item Yes No
Does the REC review the methods to identify and recruit potential participants?
Does the REC review recruitment processes to ensure that the selection of subjects will be equitable in regards to gender, religion, and ethnicity?
Does the REC identify the potential of the research for enrolling participants who are likely to be vulnerable to coercion or undue influence (such as children, prisoners, persons with mental disabilities, or persons who are economically or educationally disadvantaged)?
Does the REC consider the justification for including vulnerable populations in the research?
Does the REC consider and require that additional safeguards be included in the study to protect the rights and welfare of the subjects?
Selection of Research Participants 1 point each
Item Yes No
Does the REC consider the appropriateness of any financial or material incentives offered to participants for their participation in the research? 
Does the REC evaluate the need to obtain the child's assent?
Informed Consent 1 point each
Item Yes No
Does the REC review the process by which informed consent will be obtained (e.g., how do investigators identify potential subjects, where does the informed consent process take place, are potential subjects allowed to take the consent form home and given enough time to ask questions, etc.)?
Does the REC review which members of the research team will approach potential participants for their informed consent?
Does the REC ensure that the informed consent document is understandable to the subject population?
Informed Consent 1 point each
Suggested ways to assess the consent form might include:
• evaluate the reading level of the consent document
• have a community member read the consent form
• require investigators to assess subjects' understanding of the consent form Does the REC waive the requirement to obtain informed consent that is based on written criteria?
Does the REC waive the requirement to have a written signature on the informed consent document that is based on written criteria?
Basic Elements of Informed Consent
Does the REC evaluate whether informed consent forms contain the following basic elements of informed consent? 1 point each
Item Yes No
A statement that the study involves research
An explanation of the purposes of the research
The expected duration of the subject's participation A description of the procedures to be followed
Identification of any experimental procedures
A description of any reasonably foreseeable risks or discomforts to the participant A description of any benefits to the participant or to others that might reasonably be expected from the research A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject A statement describing the extent, if any, to which confidentiality of records identifying the participant will be maintained For research involving more than minimal risk, an explanation as to whether any medical treatments are available if injury occurs and, if so, what the treatments consist of or where further information may be obtained An explanation of whom to contact for answers to pertinent questions about research An explanation of whom to contact for answers to pertinent questions about research participants' rights A statement that participation is voluntary A statement that refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled A statement that participant may discontinue participation at any time without penalty or loss of benefits to which the participant is otherwise entitled
COMMUNICATING A DECISION (APPROVAL LETTER) Maximum 5 POINTS
Please answer the following questions regarding the approval letter sent to the PI. If no approval letter is sent to the investigator, please skip this section. 
WORKLOAD OF THE REC (0 POINTS)
